UROVIVE Trademark

Trademark Overview

On Tuesday, January 7, 2020, a trademark application was filed for UROVIVE with the United States Patent and Trademark Office. The USPTO has given the UROVIVE trademark a serial number of 88749764. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 28, 2020. This trademark is owned by TissueTech, Inc.. The UROVIVE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Biological tissue; biologic tissue products; umbilical cord tissue; biologic tissue products, namely, allografts made from human umbilical cord tissue for use after a prostatectomy to accelerate recovery of urinary and sexual function; biological tissue grafts; therapeutic products in the nature of biological tissue preparations, comprised of human amniotic membrane tissue, human umbilical cord tissue, or some combination thereof; pharmaceutical preparations, comprised of human amniotic membrane tissue, human umbilical cord tissue, or some combination thereof, for use during surgery and for wound care, tissue repair, for subsequent surgical implantation, for prostate surgery, or for restoration of bladder, urinary and sexual function

Medical devices and instruments related to prostate surgery and the recovery of urinary and sexual function; urological and gynecological devices to treat urinary incontinence or sexual dysfunction
urovive

General Information

Serial Number88749764
Word MarkUROVIVE
Filing DateTuesday, January 7, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 28, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiological tissue; biologic tissue products; umbilical cord tissue; biologic tissue products, namely, allografts made from human umbilical cord tissue for use after a prostatectomy to accelerate recovery of urinary and sexual function; biological tissue grafts; therapeutic products in the nature of biological tissue preparations, comprised of human amniotic membrane tissue, human umbilical cord tissue, or some combination thereof; pharmaceutical preparations, comprised of human amniotic membrane tissue, human umbilical cord tissue, or some combination thereof, for use during surgery and for wound care, tissue repair, for subsequent surgical implantation, for prostate surgery, or for restoration of bladder, urinary and sexual function
Goods and ServicesMedical devices and instruments related to prostate surgery and the recovery of urinary and sexual function; urological and gynecological devices to treat urinary incontinence or sexual dysfunction

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, January 10, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTissueTech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33126

Trademark Events

Event DateEvent Description
Monday, September 28, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, September 28, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, March 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION WRITTEN
Monday, March 16, 2020ASSIGNED TO EXAMINER
Friday, January 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 10, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

urovive tissue human urinary sexual cord umbilical function biological products surgery